About MD Biosciences

What does MD Biosciences do?

MD Biosciences is a provider of discovery- and clinical-stage pharmaceutical and biotechnological services, including CLIA-certified clinical laboratory testing such as cancer mutational testing; preclinical lab services with biomarker studies, histology/IHC, and cell-based assays; biomarker analysis; and animal and cellular disease models for fibrosis, arthritis, cancer, dermal/skin conditions, immune response, metabolic diseases, IBD, respiratory diseases, and sepsis.

Who are MD Biosciences's competitors?

MD Biosciences's competitors and similar companies include GL Chemtec, Paragon Bioservices, Northeast Biolab, TCG Supplies, and Biorasi.

Where is MD Biosciences headquartered?

MD Biosciences is headquartered in United States.

How many employees does MD Biosciences have?

MD Biosciences has 1,000 employees 🔒.

When was MD Biosciences founded?

MD Biosciences was founded in 2010 🔒.

What sector and industry vertical is MD Biosciences in?

MD Biosciences is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for MD Biosciences

Who are the top strategic acquirers in MD Biosciences's sector and industry

Top strategic M&A buyers and acquirers in MD Biosciences's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for MD Biosciences?

Top strategic M&A buyers groups and sectors for MD Biosciences include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in MD Biosciences's sector and industry vertical

Which are the top PE firms investing in MD Biosciences's sector and industry vertical?

Top PE firms investing in MD Biosciences's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in MD Biosciences's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in MD Biosciences's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in MD Biosciences's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to MD Biosciences include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in MD Biosciences's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for MD Biosciences?

The key public trading comparables and valuation benchmarks for MD Biosciences include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for MD Biosciences for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for MD Biosciences with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in MD Biosciences's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for MD Biosciences with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in MD Biosciences's' sector and industry vertical?

Access recent funding rounds and capital raises in MD Biosciences's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.